ADVERSE REACTIONS SECTION.


ADVERSE REACTIONS. Allergicsensitization has been reported following both oral and parenteraladministration of folic acid.

BOXED WARNING SECTION.


WARNING: Accidental overdose of iron-containing products is aleading cause of fatal poisoning in children under 6. KEEP THIS PRODUCTOUT OF THE REACH OF CHILDREN. In case of accidental overdose, calla doctor or poison control center immediately.

CONTRAINDICATIONS SECTION.


CONTRAINDICATIONS. This product is contraindicated in patients witha known hypersensitivity to any of the ingredients.

DOSAGE & ADMINISTRATION SECTION.


DOSAGE AND ADMINISTRATION. One tablet and one capsule daily or as directed by physician.

HOW SUPPLIED SECTION.


HOW SUPPLIED. Six child-resistant blister packs of tablets and capsules each- NDC 0178-0821-30 To report serious adverse eventor obtain product information, call (210) 696-8400. Please consult your health careprovider with any dietary concerns. 51072C01 Rev 011130DHA capsules manufactured for: MISSIONPHARMACAL COMPANY San Antonio, TX USA 78230 1355 Prenatal tablets manufactured by: MISSIONPHARMACAL COMPANY San Antonio, TX USA 78230 1355 Ferr-Ease(TM) Dual-iron delivery Trademark of Mission Pharmacal Company U.S. Patent No.6,521,247 lifesDHA(TM)HEALTHY BRAIN, EYES, HEART.

INDICATIONS & USAGE SECTION.


INDICATIONS. CitraNatal (R) 90 DHA is multivitamin/mineral prescription drugindicated for use in improving the nutritional status of women priorto conception, throughout pregnancy, and in the postnatal period forboth lactating and nonlactating mothers.

OTC - ACTIVE INGREDIENT SECTION.


DESCRIPTION. CitraNatal (R) 90 DHA is prescription prenatal/postnatal multivitamin/mineraltablet with Ferr-Ease (R), patented dual-irondelivery comprising both quick release and slow release iron, anda capsule of an essential fatty acid. The prenatal vitamin is white,oval multivitamin/mineral tablet. The tablet is debossed CN 90 onone side and 0821 on the other. The essential fatty acid DHA capsuleis caramel colored and contains light yellow to orange semi-solidmixture. Each prenatal tablet contains:Vitamin (Ascorbic acid)120 mgCalcium (Calcium citrate)159 mgIron (Carbonyl iron, ferrous gluconate)90 mgVitamin D3 (Cholecalciferol)400 IUVitamin (dl-alpha tocopheryl acetate)30 IUThiamin (Vitamin B1)3 mgRiboflavin (Vitamin B2)3.4 mgNiacinamide (Vitamin B3)20 mgVitamin B6 (Pyridoxine HCl)20 mgFolic Acid1 mgIodine (Potassium iodide)150 mcgZinc (Zinc oxide)25 mgCopper (Cupric oxide)2 mgDocusate Sodium50 mgEach DHA gelatin capsule contains:Docosahexaenoic Acid(DHA, 40% from 750 mg Algal Oil)300 mgEicosapentaenoic Acid (EPA)Not more than 0.750 mgOther ingredients in DHAgelatin capsule: Gelatin, glycerin, sunflower oil, water, caramelcolor, tocopherols, rosemary extract, sunflower lecithin, ascorbylpalmitate.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL.


CitraNatal (R) 90 DHA Carton NDC: 0178-0821-30 citranatal-90-dha-carton.

PRECAUTIONS SECTION.


PRECAUTIONS. Folic acid in doses above 0.1 mg daily may obscurepernicious anemia in that hematologic remission can occur while neurologicalmanifestations progress.

STORAGE AND HANDLING SECTION.


STORAGE. Store at 20-25C(68-77F)NOTICE: Contact with moisture can discolor or erode the tablet. HOW SUPPLIED. Six child-resistant blister packs of tablets and capsules each- NDC 0178-0821-30 To report serious adverse eventor obtain product information, call (210) 696-8400. Please consult your health careprovider with any dietary concerns. 51072C01 Rev 011130DHA capsules manufactured for: MISSIONPHARMACAL COMPANY San Antonio, TX USA 78230 1355 Prenatal tablets manufactured by: MISSIONPHARMACAL COMPANY San Antonio, TX USA 78230 1355 Ferr-Ease(TM) Dual-iron delivery Trademark of Mission Pharmacal Company U.S. Patent No.6,521,247 lifesDHA(TM)HEALTHY BRAIN, EYES, HEART.

WARNINGS SECTION.


WARNING. Ingestion of more than grams of omega-3 fattyacids per day has been shown to have potential antithrombotic effects,including an increased bleeding time and INR. Administration of omega-3fatty acids should be avoided in patients on anticoagulants and inthose known to have an inherited or acquired bleeding diathesis.WARNING: Folic acidalone is improper therapy in the treatment of pernicious anemia andother megaloblastic anemias where vitamin 12 is deficient.